{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:58:57Z","timestamp":1783468737321,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"DOI":"10.7759\/cureus.61914","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T01:27:13Z","timestamp":1717810033000},"source":"Crossref","is-referenced-by-count":1,"title":["\u201cVery\u201d Very Late Stent Thrombosis: A Detailed Look at Two Cases"],"prefix":"10.7759","author":[{"given":"Adhvithi","family":"Pingili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiavax J","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Kaliyadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia HM","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, et al.. Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 consensus document. Circulation. 2018, 137:2635-50. 10.1161\/CIRCULATIONAHA.117.029289","journal-title":"Circulation"},{"key":"ref2","article-title":"\u201cVery\u201d very late stent thrombosis: acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation","volume":"26","author":"Kaliyadan A","year":"2014","unstructured":"Kaliyadan A, Siu H, Fischman DL, et al.. \u201cVery\u201d very late stent thrombosis: acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation. J Invasive Cardiol. 2014, 26:413-16.","journal-title":"J Invasive Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.007822","article-title":"Risk factors and long-term clinical outcomes of second-generation drug-eluting stent thrombosis","volume":"12","author":"Kuramitsu S","year":"2019","unstructured":"Kuramitsu S, Ohya M, Shinozaki T, et al.. Risk factors and long-term clinical outcomes of second-generation drug-eluting stent thrombosis. Circ Cardiovasc Interv. 2019, 12:e007822. 10.1161\/CIRCINTERVENTIONS.119.007822","journal-title":"Circ Cardiovasc Interv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026492","article-title":"Intravascular imaging for guiding in-stent restenosis and stent thrombosis therapy","volume":"11","author":"Erdogan E","year":"2022","unstructured":"Erdogan E, Bajaj R, Lansky A, Mathur A, Baumbach A, Bourantas CV. Intravascular imaging for guiding in-stent restenosis and stent thrombosis therapy. J Am Heart Assoc. 2022, 11:e026492. 10.1161\/JAHA.122.026492","journal-title":"J Am Heart Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)","volume":"136","author":"Adriaenssens T","year":"2017","unstructured":"Adriaenssens T, Joner M, Godschalk TC, et al.. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation. 2017, 136:1007-21. 10.1161\/CIRCULATIONAHA.117.026788","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10641968909035393","article-title":"Effects of calcium antagonists on atherogenesis","volume":"11","author":"Kiowski W","year":"1989","unstructured":"Kiowski W, Erne P, B\u00fchler FR. Effects of calcium antagonists on atherogenesis. Clin Exp Hypertens A. 1989, 11:1085-96. 10.3109\/10641968909035393","journal-title":"Clin Exp Hypertens A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry","volume":"37","author":"Souteyrand G","year":"2016","unstructured":"Souteyrand G, Amabile N, Mangin L, et al.. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016, 37:1208-16. 10.1093\/eurheartj\/ehv711","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001878","article-title":"Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation","volume":"8","author":"Lee SY","year":"2015","unstructured":"Lee SY, Hur SH, Lee SG, et al.. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv. 2015, 8:e001878. 10.1161\/CIRCINTERVENTIONS.114.001878","journal-title":"Circ Cardiovasc Interv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.046599","article-title":"Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry","volume":"125","author":"Kimura T","year":"2012","unstructured":"Kimura T, Morimoto T, Nakagawa Y, et al.. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012, 125:584-91. 10.1161\/CIRCULATIONAHA.111.046599","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.679703","article-title":"Dual antiplatelet therapy vs. single antiplatelet therapy after transcatheter aortic valve replacement: an updated systematic review and meta-analysis","volume":"8","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Shen L, Yang W, He B. Dual antiplatelet therapy vs. single antiplatelet therapy after transcatheter aortic valve replacement: an updated systematic review and meta-analysis. Front Cardiovasc Med. 2021, 8:679703. 10.3389\/fcvm.2021.679703","journal-title":"Front Cardiovasc Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306251","article-title":"Neoatherosclerosis from a pathologist's point of view","volume":"35","author":"Romero ME","year":"2015","unstructured":"Romero ME, Yahagi K, Kolodgie FD, Virmani R. Neoatherosclerosis from a pathologist's point of view. Arterioscler Thromb Vasc Biol. 2015, 35:e43-9. 10.1161\/ATVBAHA.115.306251","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.01.070","article-title":"ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients","volume":"51","author":"Chechi T","year":"2008","unstructured":"Chechi T, Vecchio S, Vittori G, et al.. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. J Am Coll Cardiol. 2008, 51:2396-402. 10.1016\/j.jacc.2008.01.070","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001039","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton JS","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al.. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:e4-e17. 10.1161\/CIR.0000000000001039","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.512","article-title":"Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Bittl JA","year":"2016","unstructured":"Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68:1116-39. 10.1016\/j.jacc.2016.03.512","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri L","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, et al.. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014, 371:2155-66. 10.1056\/NEJMoa1409312","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel PA","year":"2010","unstructured":"Gurbel PA, Bliden KP, Butler K, et al.. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation. 2010, 121:1188-99. 10.1161\/CIRCULATIONAHA.109.919456","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261604-very-very-late-stent-thrombosis-a-detailed-look-at-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T01:27:18Z","timestamp":1717810038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261604-very-very-late-stent-thrombosis-a-detailed-look-at-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.61914","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}